Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMED.L Regulatory News (MED)

  • There is currently no data for MED

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

30 May 2018 07:00

RNS Number : 5939P
Medaphor Group PLC
30 May 2018
 

30 May 2018

MedaPhor Group plc ("the Group" the "Company")

 

Grant of options

 

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces that the following additional share options over the Ordinary Shares of the Company have been granted to the Executive Directors.

 

Name of Director

Position

Number of share options

Stuart Gall

Chief Executive

2,437,000

Nicholas Sleep

Chief Technology Officer

1,605,000

Ian Whittaker

Chief Operating Officer

1,000,000

Wilson Jennings

Finance Director

1,000,000

 

The exercise price of the options is 11.25p per Ordinary Share.

In respect of each director's share options set out above, one third of the above share options will vest once the closing mid-market price of the Company's Ordinary Shares reaches an average of least 25p per share for a continuous period of 20 business days; one third of the share options will vest once the closing mid-market price of the Company's Ordinary Shares reaches an average of at least 37.5p per share for a continuous period of 20 business days and the final third of the share options will vest once the closing mid-market price of the Company's Ordinary Shares reaches an average of at least 50p per share for a continuous period of 20 business days. Any unexercised options will lapse on 29 May 2028.

 

 

Enquiries:

 

MedaPhor Group plc

www.medaphor.com

Stuart Gall, CEO

Ian Whittaker, COO

Tel: +44 (0)29 2075 6534

Cenkos Securities

Tel: +44 (0)20 7397 8900

Camilla Hume (Nominated Advisor)

Michael Johnson / Julian Morse (Corporate Broking)

Walbrook PR

Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com

Paul McManus / Anna Dunphy

Mob: +44 (0)7980 541 893 / Mob: +44 (0)7876 741 001

 

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Stuart Gall

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

MedaPhor Group plc

b)

 

LEI

 

 

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 1p each

 

 

ISIN: GB00BN791Q39

b)

 

Nature of the transaction

 

 

Grant of options over ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

2,437,000 share options

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

N/A

 

 

 

 

 

e)

 

Date of the transaction

 

 

29 May 2018

f)

 

Place of the transaction

 

 

Outside a trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Nicholas Sleep

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Technical Officer

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

MedaPhor Group plc

b)

 

LEI

 

 

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 1p each

 

 

ISIN: GB00BN791Q39

b)

 

Nature of the transaction

 

 

Grant of options over ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

1,605,000 share options

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

N/A

 

 

 

 

 

e)

 

Date of the transaction

 

 

29 May 2018

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Ian Whittaker

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Operating Officer

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

MedaPhor Group plc

b)

 

LEI

 

 

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 1p each

 

 

ISIN: GB00BN791Q39

b)

 

Nature of the transaction

 

 

Grant of options over ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

1,000,000 share options

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

N/A

 

 

 

 

 

e)

 

Date of the transaction

 

 

29 May 2018

f)

 

Place of the transaction

 

 

Outside a trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Wilson Jennings

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Finance Director

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

MedaPhor Group plc

b)

 

LEI

 

 

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 1p each

 

 

ISIN: GB00BN791Q39

b)

 

Nature of the transaction

 

 

Grant of options over ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

1,000,000 share options

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

N/A

 

 

 

 

 

e)

 

Date of the transaction

 

 

29 May 2018

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFERELIAFIT
Date   Source Headline
24th Oct 20062:34 pmRNSDirectorate Change
23rd Oct 20062:14 pmRNSHolding(s) in Company
13th Oct 20062:31 pmRNSHolding(s) in Company
12th Oct 20069:44 amRNSHolding(s) in Company
10th Oct 200610:37 amRNSDirector/PDMR Shareholding
5th Oct 20069:52 amRNSHolding(s) in Company
4th Oct 200610:53 amRNSDirector/PDMR Shareholding
2nd Oct 20062:57 pmRNSResult of EGM
6th Sep 20067:03 amRNSPlacing
6th Sep 20067:03 amRNSInterim Results
31st Aug 20069:09 amRNSHolding(s) in Company
27th Jul 20067:00 amRNSBoard Appointment
15th Jun 20064:26 pmRNSHolding(s) in Company
14th Jun 20062:58 pmRNSHolding(s) in Company
23rd May 20063:30 pmRNSAGM Statement
27th Apr 200610:00 amRNSPublication of Annual Report
13th Mar 200611:56 amRNSBlocklisting Interim Review
22nd Feb 20067:01 amRNSFinal Results
8th Feb 200610:29 amRNSAppointment of Adviser
4th Jan 20063:25 pmRNSDirectorate Change
29th Dec 20057:00 amRNSShipment of First Product
25th Nov 200512:33 pmRNSDirector/PDMR Shareholding
26th Oct 20057:00 amRNSDirectorate Change
6th Oct 20054:21 pmRNSDirector/PDMR Shareholding
29th Sep 20057:03 amRNSInterim Results
9th Sep 200510:49 amRNSAdditional Listing
8th Sep 20053:52 pmRNSBlocklisting Interim Review
9th Aug 20054:57 pmRNSTrading Statement
12th Jul 20057:00 amRNSAppointment to the Board
24th Jun 20054:39 pmRNSDirector Shareholding
3rd Jun 20057:00 amRNSTrading Statement
15th Apr 20057:00 amRNSPreliminary Results
15th Apr 20057:00 amRNSDirectorate Change
21st Mar 20057:00 amRNSUMC Silicon Wafer Production
7th Mar 20052:55 pmRNSBlocklisting
21st Jan 20059:14 amRNSAdjustment to Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.